fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.

New lasalocid MRLs relieve export restrictions for broilers

Broiler producers who want more diversity in their anticoccidial-rotation plan can now consider the ionophore lasalocid without worrying about it putting a damper on exports, says Jon Schaeffer, DVM, director of poultry veterinary services, Zoetis.

After reviewing data demonstrating the compound is rapidly depleted from tissues, Japan and the EU recently raised the maximum residue limits (MRL) permitted for lasalocid (Table 1). “This should relieve any concerns related to MRLs that US broiler producers have about exporting to these regions,” he says.

Table 1. Lasalocid maximum residue limits (ug/Kg) in the EU and Japan

Table 1. Lasalocid maximum residue limits (ug/Kg) in the EU and Japan

Lasalocid is marketed as Avatec® (lasalocid). In the US, it has a zero-day withdrawal time and can be fed all the way to processing, the veterinarian explains.

The former MRLs for lasalocid in Japan existed because the product’s previous sponsors had not filed an application there to establish an MRL. Japan, therefore, defaulted to the lowest level possible — 10 ug/Kg — which made it virtually impossible for poultry producers using lasalocid to export their meat to that country, Schaeffer says.

The changes in MRLs for lasalocid should be welcome news for broiler producers looking to add another field-proven anticoccidial to their rotation program, he says.

Lasalocid is a divalent ionophore with a unique molecular structure, Schaeffer explains. It therefore can be used to break up resistance associated with the continuous use of monovalent ionophores such as monensin, narasin and salinomycin.

 

 

 

 

 

 

 




Posted on February 15, 2017

tags: , , , , ,
RELATED NEWS
  • Planning anticoccidial rotation strategies: Consider the consequences

    Anticoccidial rotation strategies help reduce the health and economic impact of coccidiosis, while preserving the efficacy of the limited range of tools available for managing it.

  • Successful ABF production: Mastered technique or corporate culture?

    Indiana's Miller Poultry's owner and president Galen Miller and production manager Stephen Shepard discuss their experiences, priorities, management style and business philosophy that led to 30% growth over the past year.

  • Hofacre: There’s always room for improvement with Salmonella

    Most US poultry companies are doing an “outstanding job” controlling Salmonella, but there's always room for improvement.

  • ABF: ‘It’s not for everybody’

    While the industry moves ahead with ABF production, we must recognize — and also respect — that not every poultry producer has the business model, market or even the inclination to deliberately withhold FDA-approved medications from their birds.




You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.